MULTISYSTEM INFLAMMATORY SYNDROME

MULTISYSTEM INFLAMMATORY SYNDROME was reported 173 times

MULTISYSTEM INFLAMMATORY SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Glycolipid Disialoganglioside-directed Antibody [EPC] 1 0.0009
1 CD38-directed Cytolytic Antibody [EPC] 5 0.0009
2 Interferon alfa-2b [EPC] 1 0.0005
3 Provitamin D2 Compound [EPC] 16 0.0005
4 Asparagine-specific Enzyme [EPC] 4 0.0003
5 Interleukin-6 Receptor Antagonist [EPC] 27 0.0002
6 Interleukin-1 Receptor Antagonist [EPC] 3 0.0002
7 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 2 0.0002
8 Human Immunoglobulin G [EPC] 3 0.0001
9 Vitamin K [EPC] 1 0.0001
10 Interleukin-17A Antagonist [EPC] 4 0.0001
11 Factor Xa Inhibitor [EPC] 28 0.0001
12 CD30-directed Immunoconjugate [EPC] 1 0.0001
13 Histamine-1 Receptor Antagonist [EPC] 8 0.0001
14 Sulfone [EPC] 1 0.0001
15 CD20-directed Cytolytic Antibody [EPC] 21 0.0001
16 Vitamin D [EPC] 20 0.0001
17 Vitamin C [EPC] 27 0.0001
18 Folate Analog Metabolic Inhibitor [EPC] 28 0.0001
19 Epidermal Growth Factor Receptor Antagonist [EPC] 3 0.0001
20 Vitamin B12 [EPC] 20 0.0001
21 Penem Antibacterial [EPC] 2 0.0001
22 Nitrofuran Antibacterial [EPC] 1 0.0001
23 Proton Pump Inhibitor [EPC] 30 0.0001
24 Programmed Death Receptor-1 Blocking Antibody [EPC] 5 0.0001
25 P2Y12 Platelet Inhibitor [EPC] 6 0.0001
26 Corticosteroid [EPC] 64 0.0000
27 Alkylating Drug [EPC] 12 0.0000
28 Leukocyte Growth Factor [EPC] 7 0.0000
29 Programmed Death Ligand-1 Blocker [EPC] 1 0.0000
30 Nucleoside Metabolic Inhibitor [EPC] 11 0.0000
31 Azole Antifungal [EPC] 6 0.0000
32 Tumor Necrosis Factor Blocker [EPC] 37 0.0000
33 Proteasome Inhibitor [EPC] 4 0.0000
34 Iron Chelator [EPC] 1 0.0000
35 Aldosterone Antagonist [EPC] 5 0.0000
36 Antidote [EPC] 2 0.0000
37 Sympathomimetic-like Agent [EPC] 1 0.0000
38 Glycopeptide Antibacterial [EPC] 2 0.0000
39 Antirheumatic Agent [EPC] 3 0.0000
40 Mood Stabilizer [EPC] 6 0.0000
41 Anti-epileptic Agent [EPC] 6 0.0000
42 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
43 Benzodiazepine [EPC] 17 0.0000
44 Estrogen Receptor Antagonist [EPC] 1 0.0000
45 Nonsteroidal Anti-inflammatory Drug [EPC] 32 0.0000
46 Thalidomide Analog [EPC] 12 0.0000
47 General Anesthetic [EPC] 1 0.0000
48 Aminoglycoside Antibacterial [EPC] 1 0.0000
49 Platinum-based Drug [EPC] 6 0.0000
50 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
51 Loop Diuretic [EPC] 9 0.0000
52 Microtubule Inhibitor [EPC] 3 0.0000
53 Platelet Aggregation Inhibitor [EPC] 10 0.0000
54 Osmotic Laxative [EPC] 5 0.0000
55 BCL-2 Inhibitor [EPC] 1 0.0000
56 Angiotensin 2 Receptor Blocker [EPC] 5 0.0000
57 Fluoroquinolone Antibacterial [EPC] 2 0.0000
58 Nitroimidazole Antimicrobial [EPC] 1 0.0000
59 Kinase Inhibitor [EPC] 8 0.0000
60 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
61 Vascular Endothelial Growth Factor Inhibitor [EPC] 2 0.0000
62 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
63 Acetylcholine Release Inhibitor [EPC] 1 0.0000
64 RANK Ligand Inhibitor [EPC] 2 0.0000
65 Dihydropyridine Calcium Channel Blocker [EPC] 3 0.0000
66 Atypical Antipsychotic [EPC] 4 0.0000
67 Aromatase Inhibitor [EPC] 1 0.0000
68 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
69 alpha-Adrenergic Blocker [EPC] 1 0.0000
70 beta-Adrenergic Blocker [EPC] 2 0.0000
71 Interleukin-4 Receptor alpha Antagonist [EPC] 3 0.0000
72 Retinoid [EPC] 1 0.0000
73 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000